Last deal

$2.15M

Amount

Grant

Stage

19.07.2022

Date

2

all rounds

$4.48M

Total amount

date founded

Financing round

General

About Company
OrPro Therapeutics develops recombinant thioredoxin for cystic fibrosis treatment.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2006

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The company's modified recombinant thioredoxin targets chronic and acute conditions related to mucosal surfaces, improving efficacy while reducing off-target effects, and has potential for treating other serious obstructive pulmonary diseases beyond cystic fibrosis.
Contacts
Similar Companies
1000
BIND Therapeutics

BIND Therapeutics

The company is developing targeted and programmable therapeutics for the treatment of cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

total rounds

7

total raised

$91.85M
Pliant Therapeutics

Pliant Therapeutics

Pliant Therapeutics is a clinical stage biopharmaceutical company developing novel therapies for fibrosis.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

South San Francisco, CA, USA

total rounds

5

total raised

$694.95M
Blade Therapeutics

Blade Therapeutics

Blade Therapeutics is a drug development company focused on creating antifibrotic treatments for a range of fibrotic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

South San Francisco, CA, USA

total rounds

5

total raised

$51.5M
Resolve Therapeutics

Resolve Therapeutics

Resolve Therapeutics is a private biotechnology company focused on developing a novel targeted biologic therapy for the treatment of lupus.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Kirkland, WA, USA

total rounds

3

total raised

$8.88M

Financials

Funding Rounds
2
2

Number of Funding Rounds

$4.48M

Money Raised

Their latest funding was raised on 19.07.2022. Their latest investor U.S. Department of Defense. Their latest round Grant

Date 
Funding Round 
Investors 
Money Raised 
Lead 
17.02.2016
$2.34M
U.S. Department of Defense

U.S. Department of Defense

The U.S. Department of Defense provides military forces to deter war and protect national security.

Sector

Aerospace and Defense

Subsector

Defense

Keywords

Government, Security, Military

Location

Washington Cir NW, Washington, DC, USA

count Of Investments

198

count Of Exists

15
Co-Investors
Investors
1
1

Number of lead investors

1

Number of investors

Investor 
Lead 
Round 
Partners 
U.S. Department of Defense

U.S. Department of Defense

The U.S. Department of Defense provides military forces to deter war and protect national security.

Sector

Aerospace and Defense

Subsector

Defense

Keywords

Government, Security, Military

Location

Washington Cir NW, Washington, DC, USA

count Of Investments

198

count Of Exists

15

People

Founders
1
Peter Heifetz
Peter Heifetz

Peter Heifetz

current job

Orpro Therapeutics
Orpro Therapeutics

organization founded

1

Peter Heifetz

Employee Profiles
2
Peter Heifetz

Peter Heifetz

CEO

Jeff Raser

COO

Activity

Recent News
0